RV, O., CL, H., SH, I., A, N., & DJ, D. (2021). Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes. Cell reports. Medicine, 2(9), 100387. https://doi.org/10.1016/j.xcrm.2021.100387
Chicago Style (17th ed.) CitationRV, Overgaard, Hertz CL, Ingwersen SH, Navarria A, and Drucker DJ. "Levels of Circulating Semaglutide Determine Reductions in HbA1c and Body Weight in People with Type 2 Diabetes." Cell Reports. Medicine 2, no. 9 (2021): 100387. https://doi.org/10.1016/j.xcrm.2021.100387.
MLA (9th ed.) CitationRV, Overgaard, et al. "Levels of Circulating Semaglutide Determine Reductions in HbA1c and Body Weight in People with Type 2 Diabetes." Cell Reports. Medicine, vol. 2, no. 9, 2021, p. 100387, https://doi.org/10.1016/j.xcrm.2021.100387.